KJIM :: Korean Journal of Internal Medicine

Is there an added value for whole body scan combined with stimulated thyroglobulin testing for follow-up of differentiated thyroid cancer patients?

Sharon Giveon, Sigal Levy, Pnina Rotman-Pikielny, Rachel Chava Rosenblum, Orit Twito

Nuclear Medicine Communications.2022; 43(6): 663. CrossRef

The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer

Sha Li, Chutong Ren, Yi Gong, Fei Ye, Yulong Tang, Jiangyue Xu, Can Guo, Jiangsheng Huang

Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients

Budi Darmawan, Meutia Sari, Stefani Susilo, Achmad Hussein S. Kartamihardja

World Journal of Nuclear Medicine.2022; 21(04): 296. CrossRef

Clinicopathologic risk factors of radioactive iodine therapy based on response assessment in patients with differentiated thyroid cancer: a multicenter retrospective cohort study

Seong Young Kwon, Sang-Woo Lee, Eun Jung Kong, Keunyoung Kim, Byung Il Kim, Jahae Kim, Heeyoung Kim, Seol Hoon Park, Jisun Park, Hye Lim Park, So Won Oh, Kyoung Sook Won, Young Hoon Ryu, Joon-Kee Yoon, Soo Jin Lee, Jong Jin Lee, Ari Chong, Young Jin Jeong

European Journal of Nuclear Medicine and Molecular Imaging.2020; 47(3): 561. CrossRef

Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy

Shin Young Jeong, Sang-Woo Lee, Wan Wook Kim, Jin Hyang Jung, Won Kee Lee, Byeong-Cheol Ahn, Jaetae Lee

Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer

The Korean Journal of Internal Medicine.2018; 33(6): 1050. CrossRef

Comparison of treatment efficacy 1 and 2 years after thyroid remnant ablation with 1110 versus 5550 MBq of iodine-131 in patients with intermediate-risk differentiated thyroid cancer

Atena Aghaei, Narjess Ayati, Susan Shafiei, Bita Abbasi, S. Rasoul Zakavi

Nuclear Medicine Communications.2017; 38(11): 927. CrossRef

Meta-analysis on Successful Ablation After Low- Versus High-Dose Radioiodine Therapy in Patients With Differentiated Thyroid Carcinoma

Clinical Nuclear Medicine.2016; 41(8): 674. CrossRef

Identification of Intermediate- to High-Risk Papillary Thyroid Carcinoma Patients Who May Be Safely Managed without the Performance of Delayed Stimulated Thyroglobulin Measurements following Total Thyroidectomy and Radioactive Iodine Therapy

Kyung-Hee Kim, Min-Hee Kim, Ye-Jee Lim, Ihn Suk Lee, Ja-Seong Bae, Dong-Jun Lim, Ki Hyun Baek, Jong Min Lee, Moo-Il Kang, Bong-Yun Cha

International Journal of Endocrinology.2015; 2015: 1. CrossRef

Predictive role of nontumoral sodium iodide symporter activity and preoperative thyroid characteristics in remission process of thyroid cancer patients

Nilufer Yildirim-Poyraz, Aylin Yazgan, Elif Ozdemir, Aysegul Gozalan, Mutlay Keskin, Reyhan Ersoy, Seyda Turkolmez, Bekir Cakir

Annals of Nuclear Medicine.2014; 28(7): 623. CrossRef

Incidence and implications of negative serum thyroglobulin but positive I‐131 whole‐body scans in patients with well‐differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal

Martin H. Cherk, Peter Francis, Duncan J. Topliss, Michael Bailey, Victor Kalff

Clinical Endocrinology.2012; 76(5): 734. CrossRef

Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer

Ujjal Mallick, Clive Harmer, Beng Yap, Jonathan Wadsley, Susan Clarke, Laura Moss, Alice Nicol, Penelope M. Clark, Kate Farnell, Ralph McCready, James Smellie, Jayne A. Franklyn, Rhys John, Christopher M. Nutting, Kate Newbold, Catherine Lemon, Georgina G

New England Journal of Medicine.2012; 366(18): 1674. CrossRef

Role of [18F]-Fluorodeoxy-D-Glucose Positron Emission Tomography and Computed Tomography in the Early Detection of Persistent/Recurrent Thyroid Carcinoma in Intermediate-to-High Risk Patients Following Initial Radioactive Iodine Ablation Therapy

Min-Hee Kim, Joo Hyun O, Sun Hee Ko, Ja-Seong Bae, Dong-Jun Lim, Sung-Hoon Kim, Ki-Hyun Baek, Jong-Min Lee, Moo-Il Kang, Bong-Yun Cha, Kwang-Woo Lee

Correlation of Clinicopathological Features and Expression of Molecular Markers With Prognosis After 131I Treatment of Differentiated Thyroid Carcinoma

Chunxia Qin, Wei Cau, Yongxue Zhang, Fabian Pius Mghanga, Xiaoli Lan, Zairong Gao, Rui An

Clinical Nuclear Medicine.2012; 37(3): e40. CrossRef

The significance of simultaneous measurement of serum thyroglobulin and thyroglobulin antibody during the follow up of patients with differentiated thyroid carcinoma

Zoltán Lőcsei, Dóra Horváth, Károly Rácz, Erzsébet Toldy